Close Menu

The US Patent and Trademark Office is holding two hearings — one this week and other in March — to gather information on "independent second opinion genetic diagnostic testing" on genes that are already patented or exclusively licensed by other companies, reports Patent Docs' Donald Zuhn. USPTO is planning to gather the information it receives from the hearings and make a report to Congress.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Two researchers are calling for education for scientists on defending facts.

Researchers were among those who marched in London this weekend to call for another vote on Brexit.

Duke has agreed to pay $112.5 million to settle a lawsuit regarding its handling of data falsified by biologist Erin Potts-Kant. 

In PLOS this week: genetic factors influencing inorganic arsenic metabolism and toxicity, a germline variant in the cell adhesion molecule-coding gene DSCAM, and more.